Rodman & Renshaw comments on Cell Therapeutics Inc. (Nasdaq: CTIC) saying, "we believe that the additional requests for data ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE